Investigating resistance of glioblastoma multiforme to radiotherapy and chemotherapy

Investigating resistance of glioblastoma multiforme to radiotherapy and chemotherapy

<p>Glioblastoma multiforme (GBM) is the most common and aggressive type of brain tumour. Despite treatment with surgery, radiotherapy and temozolomide (TMZ) chemotherapy, patient survival remains poor, suggesting that GBM cells evade and resist these therapies. The insulin-like growth factor 1...

Szczegółowa specyfikacja

Opis bibliograficzny
1. autor:	Simpson, A
Kolejni autorzy:	Macaulay, V
Format:	Praca dyplomowa
Język:	English
Wydane:	2016
Hasła przedmiotowe:	Radio-resistance Glioblastoma multiforme Chemo-resistance Radiotherapy Chemotherapy Glioma

Podobne zapisy

Adjuvant uzatılmış temozolamid tedavisinin glioblastoma multiforme hastalarının sağkalımına etkisi
od: Berna YILDIRIM, i wsp.
Wydane: (2018-09-01)

Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide
od: Alexandre Ciuffi Faustino, i wsp.
Wydane: (2020-09-01)

Glioblastoma Multiforme: A Single Hospital Experience
od: Hamid Behzadnia, i wsp.
Wydane: (2015-12-01)

Hypofractionated radiotherapy part of multimodality treatment in multicentric glioblastoma multiforme: A case report
od: Vanessa Moldoveanu, i wsp.
Wydane: (2018-12-01)

Salvage Radiation Therapy for Patients With Relapsing Glioblastoma Multiforme and the Role of Slow Fractionation
od: I. Frank Ciernik, i wsp.
Wydane: (2020-12-01)

Efficacy and Safety of Hypofractionated Radiotherapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme: A Systematic Review and Meta-Analysis
od: Guixiang Liao, i wsp.
Wydane: (2019-10-01)

Effect of Zinc Sulfate on Overall Survival and Progression-Free Survival in Patients with Glioblastoma Multiforme, a Phase II Study
od: Niloofar Ahmadloo, i wsp.
Wydane: (2023-01-01)

Role of extent of resection on the survival of glioblastoma multiforme
od: Dipak Chaulagain, i wsp.
Wydane: (2023-06-01)

Small cell glioblastoma multiforme: a case series and clinicopathological update
od: Arun Kumar Yadav, i wsp.
Wydane: (2020-12-01)

Evaluation of early imaging response criteria in glioblastoma multiforme
od: Millar Barbara-Ann, i wsp.
Wydane: (2011-09-01)

Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
od: Shang-Yu Chou, i wsp.
Wydane: (2018-01-01)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
od: Xiangjun Tang, i wsp.
Wydane: (2020-11-01)

lncRNA Biomarkers of Glioblastoma Multiforme
od: Markéta Pokorná, i wsp.
Wydane: (2024-04-01)

Recurrent Glioblastoma: Where we stand
od: Sanjoy Roy, i wsp.
Wydane: (2015-01-01)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
od: Li Hu, i wsp.
Wydane: (2021-05-01)

Advances in immunotherapy for glioblastoma multiforme
od: Ahmad Bakur Mahmoud, i wsp.
Wydane: (2022-10-01)

A Case With Multicentric Glioblastoma Multiforme
od: Elif Tolgay, i wsp.
Wydane: (2008-08-01)

Changing Trends in Radiotherapy for Glioblastoma Multiforme and Effects on Normal Tissue Doses
od: Kamuran İbiş, i wsp.
Wydane: (2019-01-01)

Dosimetric comparative study of conformal radiation techniques in patients with glioblastoma multiforme
od: Sajad Ahmad Rather, i wsp.
Wydane: (2023-01-01)

Metástases intrarraquidianas de glioblastoma multiforme supratentorial da infância: relato de caso Spinal cord metastatic glioblastoma multiforme of childhood: case report
od: Patricia Imperatriz Porto Rondinelli, i wsp.
Wydane: (2002-09-01)

Prognostic factors in glioblastoma multiforme
od: Leonardo Welling, i wsp.
Wydane: (2010-12-01)

Long-term Survival of Six Patients with Glioblastoma Multiforme: Case Series and Review of the Literature
od: Shapour Omidvari, i wsp.
Wydane: (2012-04-01)

Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide
od: Lu-Ting Kuo, i wsp.
Wydane: (2017-01-01)

The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
od: Łukasz A. Poniatowski, i wsp.
Wydane: (2024-01-01)

Glioblastoma multiforme - disease overview considering sports and neurorehabilitation
od: Monika Niedźwiedzka, i wsp.
Wydane: (2024-10-01)

Salvage fractionated Stereotactic Radiotherapy (fSRT) with or without chemotherapy and immunotherapy for recurrent Glioblastoma Multiforme: A single institution experience
od: Shaakir eHasan, i wsp.
Wydane: (2015-05-01)

A Child with Glioblastoma Multiforme — Case Report
od: Anna Rozensztrauch, i wsp.
Wydane: (2020-06-01)

Evaluation Value of Serum Markers Combined with miRNA-let-7 in Chemotherapy Effect and Prognosis of Glioblastoma Multiforme
od: Jie ZHAO, i wsp.
Wydane: (2024-08-01)

The hidden architects of glioblastoma multiforme: Glioma stem cells
od: Om S. Sahoo, i wsp.
Wydane: (2024-03-01)

Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression
od: Salvatore Panza, i wsp.
Wydane: (2020-06-01)

Immunotherapeutic Approaches for Glioblastoma Treatment
od: Nasser K. Yaghi, i wsp.
Wydane: (2022-02-01)

Glioblastoma multiforme: Case report of an unusual presentation
od: Niveditha Samala, i wsp.
Wydane: (2023-01-01)

Using Light for Therapy of Glioblastoma Multiforme (GBM)
od: Alex Vasilev, i wsp.
Wydane: (2020-01-01)

Biomarkers of Glioblastoma Multiforme
od: Guru Dutta Satyarthee, i wsp.
Wydane: (2018-09-01)

Correlação clínico-topográfica em glioblastomas multiformes nas síndromes motoras: significados fisiopatológicos Clinical topographic findings in glioblastoma multiforme and the relation with motor impairment
od: Rita de Cássia G. Lucena, i wsp.
Wydane: (2006-06-01)

An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
od: Milan Teraiya, i wsp.
Wydane: (2023-04-01)

Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
od: Harpinder K. Brar, i wsp.
Wydane: (2022-12-01)

Management of glioblastoma in elderly patients: A review of the literature
od: Nektarios K. Mazarakis, i wsp.
Wydane: (2024-05-01)

HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme
od: Einthavy Arunachalam, i wsp.
Wydane: (2022-04-01)

Case report: Triple whammy: Synchronous radiotherapy induced glioblastoma multiforme and papillary thyroid cancer following nasopharyngeal carcinoma
od: Kamalanathan Palaniandy, i wsp.
Wydane: (2022-11-01)